AI GeneLab Early Detection Chronic Disease cover art

AI GeneLab Early Detection Chronic Disease

AI GeneLab Early Detection Chronic Disease

Listen for free

View show details

LIMITED TIME OFFER | £0.99/mo for the first 3 months

Premium Plus auto-renews at £8.99/mo after 3 months. Terms apply.

About this listen

 Reviewed by Dr Reza Lankarani 🫆, General SurgeonFounder | Surgical Pioneering Newsletter and Podcast Series Editorial Board Member | Genesis Journal of Surgery and MedicineAI Gene Lab is an innovative medical technology initiative dedicated to enhancing the early detection of chronic illnesses through advanced artificial intelligence. By synthesizing clinical data, medical imaging, and patient lifestyle factors, the organization develops non-invasive screening tools for conditions like diabetes, heart disease, and various cancers. Their diverse portfolio features specialized software designed to predict health risks and suggest personalized treatment dosages, such as insulin levels. Led by experts in bioinformatics and data analysis, the team is currently working to validate these systems alongside clinical professionals to ensure accuracy. Ultimately, the project aims to establish a comprehensive digital health platform that streamlines diagnostics for providers and improves global patient outcomes. Through strategic partnerships, they seek to expand these predictive technologies into the broader realms of telemedicine and international healthcare.1. SummaryAI Gene Lab is an innovative organization focused on improving early detection of chronic and complex diseases through artificial intelligence. Their core mission is to empower healthcare through AI-driven predictive tools, thereby enhancing patient outcomes and easing pressures on healthcare systems. They achieve this by combining medical knowledge with AI and data analysis to provide non-invasive tools for timely diagnosis, informed treatment decisions, and meaningful insights for patients and providers. AI Gene Lab is actively seeking strategic partners, sponsors, and accelerator programs to further its product development, clinical collaborations, and navigate regulatory requirements, with an ultimate goal of global accessibility.2. Core Mission and PhilosophyAI Gene Lab identifies a critical challenge in healthcare: "Many serious conditions are often detected late, reducing treatment effectiveness." Their foundational philosophy is to address this by leveraging AI to facilitate "faster and more accurate risk assessments" through the integration of clinical, imaging, and lifestyle data. The ultimate aim is to "enhance patient outcomes and ease pressures on healthcare systems."3. Key Offerings: AI-Based Predictive ToolsAI Gene Lab's portfolio comprises several AI-based tools, developed and refined with clinical input. These tools are primarily intended for screening and risk assessment and are currently undergoing clinical validation.Diabetes Risk Predictor: This tool "Estimates diabetes risk using hybrid classical machine learning methods trained on established datasets and patient data, analyzing factors such as age, BMI, glucose, insulin, and blood pressure."Insulin Optimal Dose Predictor: Designed to support diabetes management, it "Provides personalized insulin dosing suggestions based on blood glucose, HbA1c, BMI, age, and other health indicators."Rheumatoid Arthritis Risk Tool: Utilizes "clinical symptoms and serological markers like RF and CRP to identify individuals at higher risk, aiding early specialist referral."Skin Cancer Detection AI: Analyzes "skin lesion images to highlight potential malignancies, supporting faster dermatological evaluation."Lumbar Spine Condition Detection: Interprets "MRI scans with AI to help diagnose spinal conditions more quickly, guiding timely treatment."Hybrid ECG AI+++: This comprehensive tool "Combines cardiovascular risk factors, AI-enhanced ECG data, and lifestyle inputs to assess heart disease risk and assist early intervention."4. Team and ExpertiseAI Gene Lab boasts an interdisciplinary team with expertise in computational biology, machine learning, and healthcare innovation. The organization is led by:Dr. Sargol Aminnezhad: A bioinformatics postdoctoral researcher at the University of Tehran.Ali Karami: A PhD candidate specializing in AI and data analysis at Bayreuth University, Germany.5. Future Vision and Strategic GoalsLooking forward, AI Gene Lab has ambitious plans for expansion and impact:Comprehensive Digital Health Platform: The organization aims to "develop a comprehensive digital health platform designed to assist healthcare professionals by integrating multiple disease screenings into a single, accessible system." This platform is intended to "support early detection and personalized care, helping to expand the reach of advanced digital health technologies."Global Accessibility: With the right support, AI Gene Lab plans to "extend our platform to telemedicine services, healthcare providers, and global health initiatives, making early disease detection more accessible and effective worldwide."Partnerships and Support: To achieve these goals, AI Gene Lab is actively "seeking strategic partners, sponsors, and accelerator programs to further product development, strengthen clinical ...
No reviews yet